nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—CYP2A6—Prednisolone—multiple sclerosis	0.128	0.394	CbGbCtD
Amphetamine—CYP2D6—Fingolimod—multiple sclerosis	0.0974	0.3	CbGbCtD
Amphetamine—CYP2A6—Dexamethasone—multiple sclerosis	0.0755	0.232	CbGbCtD
Amphetamine—CARTPT—nerve—multiple sclerosis	0.0333	0.135	CbGeAlD
Amphetamine—CYP2D6—Dexamethasone—multiple sclerosis	0.0237	0.0731	CbGbCtD
Amphetamine—CARTPT—brainstem—multiple sclerosis	0.0143	0.058	CbGeAlD
Amphetamine—CARTPT—medulla oblongata—multiple sclerosis	0.00998	0.0404	CbGeAlD
Amphetamine—CARTPT—spinal cord—multiple sclerosis	0.0089	0.0361	CbGeAlD
Amphetamine—SLC6A3—nerve—multiple sclerosis	0.00857	0.0347	CbGeAlD
Amphetamine—CARTPT—nervous system—multiple sclerosis	0.0075	0.0304	CbGeAlD
Amphetamine—TAAR1—nervous system—multiple sclerosis	0.0075	0.0304	CbGeAlD
Amphetamine—MAOB—nerve—multiple sclerosis	0.00747	0.0302	CbGeAlD
Amphetamine—CARTPT—central nervous system—multiple sclerosis	0.00722	0.0292	CbGeAlD
Amphetamine—TAAR1—central nervous system—multiple sclerosis	0.00722	0.0292	CbGeAlD
Amphetamine—CARTPT—cerebellum—multiple sclerosis	0.00706	0.0286	CbGeAlD
Amphetamine—SLC6A2—nerve—multiple sclerosis	0.00691	0.028	CbGeAlD
Amphetamine—DRD2—nerve—multiple sclerosis	0.0063	0.0255	CbGeAlD
Amphetamine—CARTPT—brain—multiple sclerosis	0.00573	0.0232	CbGeAlD
Amphetamine—SLC18A2—brainstem—multiple sclerosis	0.00486	0.0197	CbGeAlD
Amphetamine—SLC6A3—brainstem—multiple sclerosis	0.00368	0.0149	CbGeAlD
Amphetamine—Pseudoephedrine—IL2—multiple sclerosis	0.00352	0.4	CrCbGaD
Amphetamine—SLC18A2—medulla oblongata—multiple sclerosis	0.00339	0.0137	CbGeAlD
Amphetamine—SLC6A4—brainstem—multiple sclerosis	0.00337	0.0137	CbGeAlD
Amphetamine—MAOB—brainstem—multiple sclerosis	0.0032	0.013	CbGeAlD
Amphetamine—SLC18A2—midbrain—multiple sclerosis	0.0031	0.0126	CbGeAlD
Amphetamine—SLC6A2—brainstem—multiple sclerosis	0.00297	0.012	CbGeAlD
Amphetamine—DRD2—brainstem—multiple sclerosis	0.0027	0.011	CbGeAlD
Amphetamine—DRD2—retina—multiple sclerosis	0.00261	0.0106	CbGeAlD
Amphetamine—SLC18A2—nervous system—multiple sclerosis	0.00255	0.0103	CbGeAlD
Amphetamine—SLC18A2—central nervous system—multiple sclerosis	0.00245	0.00994	CbGeAlD
Amphetamine—SLC22A5—retina—multiple sclerosis	0.00243	0.00984	CbGeAlD
Amphetamine—SLC18A2—cerebellum—multiple sclerosis	0.0024	0.00971	CbGeAlD
Amphetamine—SLC6A3—midbrain—multiple sclerosis	0.00234	0.0095	CbGeAlD
Amphetamine—SLC6A3—spinal cord—multiple sclerosis	0.00229	0.00927	CbGeAlD
Amphetamine—MAOB—medulla oblongata—multiple sclerosis	0.00223	0.00905	CbGeAlD
Amphetamine—SLC6A4—midbrain—multiple sclerosis	0.00215	0.0087	CbGeAlD
Amphetamine—CYP2A6—cerebellum—multiple sclerosis	0.00214	0.00867	CbGeAlD
Amphetamine—SLC6A4—spinal cord—multiple sclerosis	0.0021	0.00849	CbGeAlD
Amphetamine—SLC6A2—medulla oblongata—multiple sclerosis	0.00207	0.00838	CbGeAlD
Amphetamine—MAOB—midbrain—multiple sclerosis	0.00204	0.00827	CbGeAlD
Amphetamine—Nateglinide—SLC15A2—multiple sclerosis	0.00204	0.232	CrCbGaD
Amphetamine—MAOB—spinal cord—multiple sclerosis	0.00199	0.00807	CbGeAlD
Amphetamine—SLC18A2—brain—multiple sclerosis	0.00195	0.00789	CbGeAlD
Amphetamine—SLC6A3—nervous system—multiple sclerosis	0.00193	0.00781	CbGeAlD
Amphetamine—SLC6A3—central nervous system—multiple sclerosis	0.00186	0.00752	CbGeAlD
Amphetamine—SLC22A3—nervous system—multiple sclerosis	0.00181	0.00735	CbGeAlD
Amphetamine—SLC6A3—cerebellum—multiple sclerosis	0.00181	0.00735	CbGeAlD
Amphetamine—SLC6A4—nervous system—multiple sclerosis	0.00177	0.00715	CbGeAlD
Amphetamine—SLC22A5—medulla oblongata—multiple sclerosis	0.00176	0.00711	CbGeAlD
Amphetamine—SLC22A3—central nervous system—multiple sclerosis	0.00175	0.00708	CbGeAlD
Amphetamine—CYP2A6—brain—multiple sclerosis	0.00174	0.00705	CbGeAlD
Amphetamine—DRD2—midbrain—multiple sclerosis	0.00172	0.00698	CbGeAlD
Amphetamine—SLC6A4—central nervous system—multiple sclerosis	0.0017	0.00689	CbGeAlD
Amphetamine—MAOB—nervous system—multiple sclerosis	0.00168	0.0068	CbGeAlD
Amphetamine—CYP2D6—brainstem—multiple sclerosis	0.00162	0.00658	CbGeAlD
Amphetamine—MAOB—central nervous system—multiple sclerosis	0.00162	0.00655	CbGeAlD
Amphetamine—Ephedrine—BCHE—multiple sclerosis	0.00161	0.184	CrCbGaD
Amphetamine—SLC22A5—midbrain—multiple sclerosis	0.0016	0.0065	CbGeAlD
Amphetamine—MAOB—cerebellum—multiple sclerosis	0.00158	0.0064	CbGeAlD
Amphetamine—SLC22A5—spinal cord—multiple sclerosis	0.00157	0.00634	CbGeAlD
Amphetamine—SLC6A2—nervous system—multiple sclerosis	0.00155	0.0063	CbGeAlD
Amphetamine—SLC6A2—central nervous system—multiple sclerosis	0.0015	0.00606	CbGeAlD
Amphetamine—SLC6A3—brain—multiple sclerosis	0.00147	0.00597	CbGeAlD
Amphetamine—DRD2—nervous system—multiple sclerosis	0.00142	0.00574	CbGeAlD
Amphetamine—SLC22A3—brain—multiple sclerosis	0.00139	0.00562	CbGeAlD
Amphetamine—DRD2—central nervous system—multiple sclerosis	0.00136	0.00553	CbGeAlD
Amphetamine—SLC6A4—brain—multiple sclerosis	0.00135	0.00547	CbGeAlD
Amphetamine—DRD2—cerebellum—multiple sclerosis	0.00133	0.0054	CbGeAlD
Amphetamine—MAOB—brain—multiple sclerosis	0.00128	0.0052	CbGeAlD
Amphetamine—SLC22A5—cerebellum—multiple sclerosis	0.00124	0.00503	CbGeAlD
Amphetamine—SLC6A2—brain—multiple sclerosis	0.00119	0.00481	CbGeAlD
Amphetamine—Pseudoephedrine—TNF—multiple sclerosis	0.00119	0.135	CrCbGaD
Amphetamine—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.00114	0.00377	CcSEcCtD
Amphetamine—Myocardial infarction—Prednisolone—multiple sclerosis	0.00113	0.00375	CcSEcCtD
Amphetamine—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00111	0.0037	CcSEcCtD
Amphetamine—Infection—Azathioprine—multiple sclerosis	0.0011	0.00366	CcSEcCtD
Amphetamine—DRD2—brain—multiple sclerosis	0.00108	0.00439	CbGeAlD
Amphetamine—Urticaria—Cladribine—multiple sclerosis	0.00108	0.00359	CcSEcCtD
Amphetamine—Body temperature increased—Cladribine—multiple sclerosis	0.00108	0.00358	CcSEcCtD
Amphetamine—Abdominal pain—Cladribine—multiple sclerosis	0.00108	0.00358	CcSEcCtD
Amphetamine—Affect lability—Prednisone—multiple sclerosis	0.00107	0.00355	CcSEcCtD
Amphetamine—Psychotic disorder—Prednisone—multiple sclerosis	0.00106	0.00352	CcSEcCtD
Amphetamine—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.00104	0.00347	CcSEcCtD
Amphetamine—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.00104	0.00346	CcSEcCtD
Amphetamine—Myocardial infarction—Triamcinolone—multiple sclerosis	0.00104	0.00345	CcSEcCtD
Amphetamine—Irritability—Prednisone—multiple sclerosis	0.00104	0.00344	CcSEcCtD
Amphetamine—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.00104	0.00344	CcSEcCtD
Amphetamine—Mood swings—Prednisone—multiple sclerosis	0.00103	0.00342	CcSEcCtD
Amphetamine—Sweating—Methylprednisolone—multiple sclerosis	0.00101	0.00337	CcSEcCtD
Amphetamine—SLC22A5—brain—multiple sclerosis	0.00101	0.00409	CbGeAlD
Amphetamine—Hypersensitivity—Cladribine—multiple sclerosis	0.001	0.00333	CcSEcCtD
Amphetamine—Asthenia—Cladribine—multiple sclerosis	0.000978	0.00325	CcSEcCtD
Amphetamine—Weight decreased—Betamethasone—multiple sclerosis	0.000976	0.00324	CcSEcCtD
Amphetamine—Weight decreased—Dexamethasone—multiple sclerosis	0.000976	0.00324	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000957	0.00318	CcSEcCtD
Amphetamine—Convulsion—Mitoxantrone—multiple sclerosis	0.000951	0.00316	CcSEcCtD
Amphetamine—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000948	0.00315	CcSEcCtD
Amphetamine—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000948	0.00315	CcSEcCtD
Amphetamine—Hypertension—Mitoxantrone—multiple sclerosis	0.000948	0.00315	CcSEcCtD
Amphetamine—Myocardial infarction—Betamethasone—multiple sclerosis	0.000942	0.00313	CcSEcCtD
Amphetamine—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000942	0.00313	CcSEcCtD
Amphetamine—Chest pain—Mitoxantrone—multiple sclerosis	0.000934	0.0031	CcSEcCtD
Amphetamine—Diarrhoea—Cladribine—multiple sclerosis	0.000932	0.0031	CcSEcCtD
Amphetamine—Anxiety—Mitoxantrone—multiple sclerosis	0.000931	0.00309	CcSEcCtD
Amphetamine—Cerebrovascular accident—Methotrexate—multiple sclerosis	0.000927	0.00308	CcSEcCtD
Amphetamine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000906	0.00301	CcSEcCtD
Amphetamine—Dizziness—Cladribine—multiple sclerosis	0.000901	0.00299	CcSEcCtD
Amphetamine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000896	0.00297	CcSEcCtD
Amphetamine—Infection—Mitoxantrone—multiple sclerosis	0.00089	0.00296	CcSEcCtD
Amphetamine—Abdominal pain—Azathioprine—multiple sclerosis	0.000876	0.00291	CcSEcCtD
Amphetamine—Body temperature increased—Azathioprine—multiple sclerosis	0.000876	0.00291	CcSEcCtD
Amphetamine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000874	0.0029	CcSEcCtD
Amphetamine—Irritability—Methotrexate—multiple sclerosis	0.000867	0.00288	CcSEcCtD
Amphetamine—Vomiting—Cladribine—multiple sclerosis	0.000866	0.00288	CcSEcCtD
Amphetamine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000866	0.00288	CcSEcCtD
Amphetamine—Erectile dysfunction—Prednisone—multiple sclerosis	0.000865	0.00287	CcSEcCtD
Amphetamine—Mood swings—Methotrexate—multiple sclerosis	0.00086	0.00286	CcSEcCtD
Amphetamine—Rash—Cladribine—multiple sclerosis	0.000859	0.00285	CcSEcCtD
Amphetamine—Dermatitis—Cladribine—multiple sclerosis	0.000858	0.00285	CcSEcCtD
Amphetamine—Anorexia—Mitoxantrone—multiple sclerosis	0.000854	0.00284	CcSEcCtD
Amphetamine—Headache—Cladribine—multiple sclerosis	0.000854	0.00283	CcSEcCtD
Amphetamine—CYP2D6—nervous system—multiple sclerosis	0.000851	0.00345	CbGeAlD
Amphetamine—Weight decreased—Prednisone—multiple sclerosis	0.00085	0.00282	CcSEcCtD
Amphetamine—Depression—Prednisone—multiple sclerosis	0.000835	0.00277	CcSEcCtD
Amphetamine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000825	0.00274	CcSEcCtD
Amphetamine—Angioedema—Prednisolone—multiple sclerosis	0.000823	0.00273	CcSEcCtD
Amphetamine—Myocardial infarction—Prednisone—multiple sclerosis	0.000821	0.00273	CcSEcCtD
Amphetamine—CYP2D6—central nervous system—multiple sclerosis	0.00082	0.00332	CbGeAlD
Amphetamine—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000818	0.00272	CcSEcCtD
Amphetamine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000816	0.00271	CcSEcCtD
Amphetamine—Nausea—Cladribine—multiple sclerosis	0.000809	0.00269	CcSEcCtD
Amphetamine—CYP2D6—cerebellum—multiple sclerosis	0.000801	0.00325	CbGeAlD
Amphetamine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000799	0.00265	CcSEcCtD
Amphetamine—Somnolence—Mitoxantrone—multiple sclerosis	0.000796	0.00264	CcSEcCtD
Amphetamine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000789	0.00262	CcSEcCtD
Amphetamine—Convulsion—Prednisolone—multiple sclerosis	0.00078	0.00259	CcSEcCtD
Amphetamine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000779	0.00259	CcSEcCtD
Amphetamine—Hypertension—Prednisolone—multiple sclerosis	0.000777	0.00258	CcSEcCtD
Amphetamine—Fatigue—Mitoxantrone—multiple sclerosis	0.000772	0.00256	CcSEcCtD
Amphetamine—Constipation—Mitoxantrone—multiple sclerosis	0.000766	0.00254	CcSEcCtD
Amphetamine—Diarrhoea—Azathioprine—multiple sclerosis	0.000758	0.00252	CcSEcCtD
Amphetamine—Angioedema—Triamcinolone—multiple sclerosis	0.000757	0.00251	CcSEcCtD
Amphetamine—Angioedema—Methylprednisolone—multiple sclerosis	0.000755	0.00251	CcSEcCtD
Amphetamine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000735	0.00244	CcSEcCtD
Amphetamine—Dizziness—Azathioprine—multiple sclerosis	0.000733	0.00243	CcSEcCtD
Amphetamine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000733	0.00243	CcSEcCtD
Amphetamine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000723	0.0024	CcSEcCtD
Amphetamine—Convulsion—Triamcinolone—multiple sclerosis	0.000717	0.00238	CcSEcCtD
Amphetamine—Tachycardia—Prednisolone—multiple sclerosis	0.000717	0.00238	CcSEcCtD
Amphetamine—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000716	0.00238	CcSEcCtD
Amphetamine—Convulsion—Methylprednisolone—multiple sclerosis	0.000716	0.00238	CcSEcCtD
Amphetamine—Hypertension—Triamcinolone—multiple sclerosis	0.000715	0.00237	CcSEcCtD
Amphetamine—Hypertension—Methylprednisolone—multiple sclerosis	0.000713	0.00237	CcSEcCtD
Amphetamine—Urticaria—Mitoxantrone—multiple sclerosis	0.000712	0.00236	CcSEcCtD
Amphetamine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00071	0.00236	CcSEcCtD
Amphetamine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000708	0.00235	CcSEcCtD
Amphetamine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000708	0.00235	CcSEcCtD
Amphetamine—Vomiting—Azathioprine—multiple sclerosis	0.000705	0.00234	CcSEcCtD
Amphetamine—Anxiety—Methylprednisolone—multiple sclerosis	0.000701	0.00233	CcSEcCtD
Amphetamine—Rash—Azathioprine—multiple sclerosis	0.000699	0.00232	CcSEcCtD
Amphetamine—Dermatitis—Azathioprine—multiple sclerosis	0.000698	0.00232	CcSEcCtD
Amphetamine—Depression—Methotrexate—multiple sclerosis	0.000698	0.00232	CcSEcCtD
Amphetamine—Headache—Azathioprine—multiple sclerosis	0.000694	0.00231	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000694	0.0023	CcSEcCtD
Amphetamine—Dry mouth—Triamcinolone—multiple sclerosis	0.000689	0.00229	CcSEcCtD
Amphetamine—Angioedema—Dexamethasone—multiple sclerosis	0.000687	0.00228	CcSEcCtD
Amphetamine—Angioedema—Betamethasone—multiple sclerosis	0.000687	0.00228	CcSEcCtD
Amphetamine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000676	0.00224	CcSEcCtD
Amphetamine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000674	0.00224	CcSEcCtD
Amphetamine—Infection—Triamcinolone—multiple sclerosis	0.000671	0.00223	CcSEcCtD
Amphetamine—Sweating—Methotrexate—multiple sclerosis	0.000671	0.00223	CcSEcCtD
Amphetamine—Infection—Methylprednisolone—multiple sclerosis	0.00067	0.00222	CcSEcCtD
Amphetamine—Insomnia—Prednisolone—multiple sclerosis	0.000665	0.00221	CcSEcCtD
Amphetamine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00066	0.00219	CcSEcCtD
Amphetamine—Tachycardia—Triamcinolone—multiple sclerosis	0.00066	0.00219	CcSEcCtD
Amphetamine—Nausea—Azathioprine—multiple sclerosis	0.000658	0.00219	CcSEcCtD
Amphetamine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000658	0.00219	CcSEcCtD
Amphetamine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000653	0.00217	CcSEcCtD
Amphetamine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000652	0.00216	CcSEcCtD
Amphetamine—Convulsion—Dexamethasone—multiple sclerosis	0.000651	0.00216	CcSEcCtD
Amphetamine—Convulsion—Betamethasone—multiple sclerosis	0.000651	0.00216	CcSEcCtD
Amphetamine—CYP2D6—brain—multiple sclerosis	0.000651	0.00264	CbGeAlD
Amphetamine—Hypertension—Betamethasone—multiple sclerosis	0.000649	0.00215	CcSEcCtD
Amphetamine—Hypertension—Dexamethasone—multiple sclerosis	0.000649	0.00215	CcSEcCtD
Amphetamine—Asthenia—Mitoxantrone—multiple sclerosis	0.000643	0.00213	CcSEcCtD
Amphetamine—Anxiety—Betamethasone—multiple sclerosis	0.000637	0.00212	CcSEcCtD
Amphetamine—Anxiety—Dexamethasone—multiple sclerosis	0.000637	0.00212	CcSEcCtD
Amphetamine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000613	0.00204	CcSEcCtD
Amphetamine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000613	0.00204	CcSEcCtD
Amphetamine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000613	0.00204	CcSEcCtD
Amphetamine—Insomnia—Triamcinolone—multiple sclerosis	0.000611	0.00203	CcSEcCtD
Amphetamine—Insomnia—Methylprednisolone—multiple sclerosis	0.00061	0.00203	CcSEcCtD
Amphetamine—Infection—Betamethasone—multiple sclerosis	0.000609	0.00202	CcSEcCtD
Amphetamine—Infection—Dexamethasone—multiple sclerosis	0.000609	0.00202	CcSEcCtD
Amphetamine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000603	0.002	CcSEcCtD
Amphetamine—Agitation—Prednisone—multiple sclerosis	0.000601	0.002	CcSEcCtD
Amphetamine—Tachycardia—Betamethasone—multiple sclerosis	0.000598	0.00199	CcSEcCtD
Amphetamine—Tachycardia—Dexamethasone—multiple sclerosis	0.000598	0.00199	CcSEcCtD
Amphetamine—Angioedema—Prednisone—multiple sclerosis	0.000598	0.00199	CcSEcCtD
Amphetamine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000595	0.00198	CcSEcCtD
Amphetamine—Erythema multiforme—Methotrexate—multiple sclerosis	0.000594	0.00197	CcSEcCtD
Amphetamine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000594	0.00197	CcSEcCtD
Amphetamine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000593	0.00197	CcSEcCtD
Amphetamine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000593	0.00197	CcSEcCtD
Amphetamine—Anorexia—Dexamethasone—multiple sclerosis	0.000585	0.00194	CcSEcCtD
Amphetamine—Anorexia—Betamethasone—multiple sclerosis	0.000585	0.00194	CcSEcCtD
Amphetamine—Urticaria—Prednisolone—multiple sclerosis	0.000584	0.00194	CcSEcCtD
Amphetamine—Fatigue—Triamcinolone—multiple sclerosis	0.000583	0.00193	CcSEcCtD
Amphetamine—Fatigue—Methylprednisolone—multiple sclerosis	0.000581	0.00193	CcSEcCtD
Amphetamine—Vomiting—Mitoxantrone—multiple sclerosis	0.00057	0.00189	CcSEcCtD
Amphetamine—Convulsion—Prednisone—multiple sclerosis	0.000567	0.00188	CcSEcCtD
Amphetamine—Hypertension—Prednisone—multiple sclerosis	0.000565	0.00188	CcSEcCtD
Amphetamine—Rash—Mitoxantrone—multiple sclerosis	0.000565	0.00188	CcSEcCtD
Amphetamine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000564	0.00187	CcSEcCtD
Amphetamine—Headache—Mitoxantrone—multiple sclerosis	0.000561	0.00186	CcSEcCtD
Amphetamine—Anxiety—Prednisone—multiple sclerosis	0.000555	0.00184	CcSEcCtD
Amphetamine—Insomnia—Dexamethasone—multiple sclerosis	0.000555	0.00184	CcSEcCtD
Amphetamine—Insomnia—Betamethasone—multiple sclerosis	0.000555	0.00184	CcSEcCtD
Amphetamine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000551	0.00183	CcSEcCtD
Amphetamine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000541	0.0018	CcSEcCtD
Amphetamine—Dyspepsia—Dexamethasone—multiple sclerosis	0.00054	0.00179	CcSEcCtD
Amphetamine—Dyspepsia—Betamethasone—multiple sclerosis	0.00054	0.00179	CcSEcCtD
Amphetamine—Urticaria—Triamcinolone—multiple sclerosis	0.000537	0.00178	CcSEcCtD
Amphetamine—Urticaria—Methylprednisolone—multiple sclerosis	0.000536	0.00178	CcSEcCtD
Amphetamine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000534	0.00177	CcSEcCtD
Amphetamine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000534	0.00177	CcSEcCtD
Amphetamine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000533	0.00177	CcSEcCtD
Amphetamine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000533	0.00177	CcSEcCtD
Amphetamine—Decreased appetite—Betamethasone—multiple sclerosis	0.000533	0.00177	CcSEcCtD
Amphetamine—Nausea—Mitoxantrone—multiple sclerosis	0.000532	0.00177	CcSEcCtD
Amphetamine—Infection—Prednisone—multiple sclerosis	0.000531	0.00176	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000529	0.00176	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000529	0.00176	CcSEcCtD
Amphetamine—Fatigue—Dexamethasone—multiple sclerosis	0.000529	0.00176	CcSEcCtD
Amphetamine—Fatigue—Betamethasone—multiple sclerosis	0.000529	0.00176	CcSEcCtD
Amphetamine—Tachycardia—Prednisone—multiple sclerosis	0.000521	0.00173	CcSEcCtD
Amphetamine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000516	0.00171	CcSEcCtD
Amphetamine—Anorexia—Prednisone—multiple sclerosis	0.000509	0.00169	CcSEcCtD
Amphetamine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000501	0.00167	CcSEcCtD
Amphetamine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000501	0.00167	CcSEcCtD
Amphetamine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000498	0.00165	CcSEcCtD
Amphetamine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000497	0.00165	CcSEcCtD
Amphetamine—Urticaria—Betamethasone—multiple sclerosis	0.000487	0.00162	CcSEcCtD
Amphetamine—Urticaria—Dexamethasone—multiple sclerosis	0.000487	0.00162	CcSEcCtD
Amphetamine—Dizziness—Prednisolone—multiple sclerosis	0.000486	0.00161	CcSEcCtD
Amphetamine—Asthenia—Triamcinolone—multiple sclerosis	0.000485	0.00161	CcSEcCtD
Amphetamine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000485	0.00161	CcSEcCtD
Amphetamine—Abdominal pain—Betamethasone—multiple sclerosis	0.000485	0.00161	CcSEcCtD
Amphetamine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000485	0.00161	CcSEcCtD
Amphetamine—Body temperature increased—Betamethasone—multiple sclerosis	0.000485	0.00161	CcSEcCtD
Amphetamine—Asthenia—Methylprednisolone—multiple sclerosis	0.000484	0.00161	CcSEcCtD
Amphetamine—Insomnia—Prednisone—multiple sclerosis	0.000483	0.0016	CcSEcCtD
Amphetamine—Convulsion—Methotrexate—multiple sclerosis	0.000474	0.00157	CcSEcCtD
Amphetamine—Dyspepsia—Prednisone—multiple sclerosis	0.00047	0.00156	CcSEcCtD
Amphetamine—Chest pain—Methotrexate—multiple sclerosis	0.000466	0.00155	CcSEcCtD
Amphetamine—Decreased appetite—Prednisone—multiple sclerosis	0.000464	0.00154	CcSEcCtD
Amphetamine—Rash—Prednisolone—multiple sclerosis	0.000463	0.00154	CcSEcCtD
Amphetamine—Dermatitis—Prednisolone—multiple sclerosis	0.000463	0.00154	CcSEcCtD
Amphetamine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000461	0.00153	CcSEcCtD
Amphetamine—Fatigue—Prednisone—multiple sclerosis	0.00046	0.00153	CcSEcCtD
Amphetamine—Headache—Prednisolone—multiple sclerosis	0.00046	0.00153	CcSEcCtD
Amphetamine—Constipation—Prednisone—multiple sclerosis	0.000457	0.00152	CcSEcCtD
Amphetamine—Dizziness—Triamcinolone—multiple sclerosis	0.000447	0.00148	CcSEcCtD
Amphetamine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000446	0.00148	CcSEcCtD
Amphetamine—Dizziness—Methylprednisolone—multiple sclerosis	0.000446	0.00148	CcSEcCtD
Amphetamine—Infection—Methotrexate—multiple sclerosis	0.000443	0.00147	CcSEcCtD
Amphetamine—Asthenia—Dexamethasone—multiple sclerosis	0.00044	0.00146	CcSEcCtD
Amphetamine—Asthenia—Betamethasone—multiple sclerosis	0.00044	0.00146	CcSEcCtD
Amphetamine—Nateglinide—ALB—multiple sclerosis	0.000438	0.0498	CrCbGaD
Amphetamine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000437	0.00145	CcSEcCtD
Amphetamine—Nausea—Prednisolone—multiple sclerosis	0.000437	0.00145	CcSEcCtD
Amphetamine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000431	0.00143	CcSEcCtD
Amphetamine—Vomiting—Triamcinolone—multiple sclerosis	0.00043	0.00143	CcSEcCtD
Amphetamine—Vomiting—Methylprednisolone—multiple sclerosis	0.000429	0.00142	CcSEcCtD
Amphetamine—Rash—Triamcinolone—multiple sclerosis	0.000426	0.00141	CcSEcCtD
Amphetamine—Dermatitis—Triamcinolone—multiple sclerosis	0.000426	0.00141	CcSEcCtD
Amphetamine—Anorexia—Methotrexate—multiple sclerosis	0.000425	0.00141	CcSEcCtD
Amphetamine—Rash—Methylprednisolone—multiple sclerosis	0.000425	0.00141	CcSEcCtD
Amphetamine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000425	0.00141	CcSEcCtD
Amphetamine—Urticaria—Prednisone—multiple sclerosis	0.000424	0.00141	CcSEcCtD
Amphetamine—Headache—Triamcinolone—multiple sclerosis	0.000423	0.00141	CcSEcCtD
Amphetamine—Headache—Methylprednisolone—multiple sclerosis	0.000422	0.0014	CcSEcCtD
Amphetamine—Abdominal pain—Prednisone—multiple sclerosis	0.000422	0.0014	CcSEcCtD
Amphetamine—Body temperature increased—Prednisone—multiple sclerosis	0.000422	0.0014	CcSEcCtD
Amphetamine—Diarrhoea—Dexamethasone—multiple sclerosis	0.00042	0.00139	CcSEcCtD
Amphetamine—Diarrhoea—Betamethasone—multiple sclerosis	0.00042	0.00139	CcSEcCtD
Amphetamine—Dizziness—Dexamethasone—multiple sclerosis	0.000406	0.00135	CcSEcCtD
Amphetamine—Dizziness—Betamethasone—multiple sclerosis	0.000406	0.00135	CcSEcCtD
Amphetamine—Insomnia—Methotrexate—multiple sclerosis	0.000404	0.00134	CcSEcCtD
Amphetamine—Nausea—Triamcinolone—multiple sclerosis	0.000401	0.00133	CcSEcCtD
Amphetamine—Nausea—Methylprednisolone—multiple sclerosis	0.000401	0.00133	CcSEcCtD
Amphetamine—Dyspnoea—Methotrexate—multiple sclerosis	0.000398	0.00132	CcSEcCtD
Amphetamine—Somnolence—Methotrexate—multiple sclerosis	0.000397	0.00132	CcSEcCtD
Amphetamine—Hypersensitivity—Prednisone—multiple sclerosis	0.000393	0.00131	CcSEcCtD
Amphetamine—Dyspepsia—Methotrexate—multiple sclerosis	0.000393	0.0013	CcSEcCtD
Amphetamine—Vomiting—Betamethasone—multiple sclerosis	0.00039	0.00129	CcSEcCtD
Amphetamine—Vomiting—Dexamethasone—multiple sclerosis	0.00039	0.00129	CcSEcCtD
Amphetamine—Decreased appetite—Methotrexate—multiple sclerosis	0.000388	0.00129	CcSEcCtD
Amphetamine—Rash—Dexamethasone—multiple sclerosis	0.000387	0.00128	CcSEcCtD
Amphetamine—Rash—Betamethasone—multiple sclerosis	0.000387	0.00128	CcSEcCtD
Amphetamine—Dermatitis—Dexamethasone—multiple sclerosis	0.000386	0.00128	CcSEcCtD
Amphetamine—Dermatitis—Betamethasone—multiple sclerosis	0.000386	0.00128	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000385	0.00128	CcSEcCtD
Amphetamine—Fatigue—Methotrexate—multiple sclerosis	0.000385	0.00128	CcSEcCtD
Amphetamine—Headache—Betamethasone—multiple sclerosis	0.000384	0.00128	CcSEcCtD
Amphetamine—Headache—Dexamethasone—multiple sclerosis	0.000384	0.00128	CcSEcCtD
Amphetamine—Asthenia—Prednisone—multiple sclerosis	0.000383	0.00127	CcSEcCtD
Amphetamine—Diarrhoea—Prednisone—multiple sclerosis	0.000365	0.00121	CcSEcCtD
Amphetamine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000365	0.00121	CcSEcCtD
Amphetamine—Nausea—Betamethasone—multiple sclerosis	0.000364	0.00121	CcSEcCtD
Amphetamine—Nausea—Dexamethasone—multiple sclerosis	0.000364	0.00121	CcSEcCtD
Amphetamine—Urticaria—Methotrexate—multiple sclerosis	0.000355	0.00118	CcSEcCtD
Amphetamine—Dizziness—Prednisone—multiple sclerosis	0.000353	0.00117	CcSEcCtD
Amphetamine—Abdominal pain—Methotrexate—multiple sclerosis	0.000353	0.00117	CcSEcCtD
Amphetamine—Body temperature increased—Methotrexate—multiple sclerosis	0.000353	0.00117	CcSEcCtD
Amphetamine—Vomiting—Prednisone—multiple sclerosis	0.00034	0.00113	CcSEcCtD
Amphetamine—Rash—Prednisone—multiple sclerosis	0.000337	0.00112	CcSEcCtD
Amphetamine—Dermatitis—Prednisone—multiple sclerosis	0.000336	0.00112	CcSEcCtD
Amphetamine—Headache—Prednisone—multiple sclerosis	0.000335	0.00111	CcSEcCtD
Amphetamine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000329	0.00109	CcSEcCtD
Amphetamine—Asthenia—Methotrexate—multiple sclerosis	0.00032	0.00106	CcSEcCtD
Amphetamine—Nausea—Prednisone—multiple sclerosis	0.000317	0.00105	CcSEcCtD
Amphetamine—Diarrhoea—Methotrexate—multiple sclerosis	0.000305	0.00101	CcSEcCtD
Amphetamine—DRD2—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.000296	0.0025	CbGpPWpGaD
Amphetamine—Dizziness—Methotrexate—multiple sclerosis	0.000295	0.00098	CcSEcCtD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000295	0.00249	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000294	0.00248	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000288	0.00243	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—SRM—multiple sclerosis	0.000284	0.0024	CbGpPWpGaD
Amphetamine—Vomiting—Methotrexate—multiple sclerosis	0.000284	0.000942	CcSEcCtD
Amphetamine—Rash—Methotrexate—multiple sclerosis	0.000281	0.000934	CcSEcCtD
Amphetamine—Dermatitis—Methotrexate—multiple sclerosis	0.000281	0.000934	CcSEcCtD
Amphetamine—TAAR1—Signaling by GPCR—CCL3—multiple sclerosis	0.000281	0.00237	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CCR2—multiple sclerosis	0.00028	0.00236	CbGpPWpGaD
Amphetamine—Headache—Methotrexate—multiple sclerosis	0.00028	0.000928	CcSEcCtD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000279	0.00236	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.000275	0.00232	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—PTGER4—multiple sclerosis	0.00027	0.00228	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000269	0.00227	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—RGS1—multiple sclerosis	0.000269	0.00227	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000268	0.00226	CbGpPWpGaD
Amphetamine—DRD2—Hypothetical Network for Drug Addiction—MAPK1—multiple sclerosis	0.000268	0.00226	CbGpPWpGaD
Amphetamine—Nausea—Methotrexate—multiple sclerosis	0.000265	0.00088	CcSEcCtD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000263	0.00222	CbGpPWpGaD
Amphetamine—MAOB—Biological oxidations—POMC—multiple sclerosis	0.000263	0.00222	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000261	0.0022	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000258	0.00218	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000257	0.00217	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—GPR65—multiple sclerosis	0.000255	0.00215	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CCR2—multiple sclerosis	0.000254	0.00214	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—POMC—multiple sclerosis	0.000249	0.0021	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—CCL2—multiple sclerosis	0.000244	0.00206	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—S1PR1—multiple sclerosis	0.000243	0.00205	CbGpPWpGaD
Amphetamine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000241	0.00204	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—SRM—multiple sclerosis	0.00024	0.00203	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000238	0.00201	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000235	0.00198	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000235	0.00198	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CNR1—multiple sclerosis	0.000234	0.00198	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000233	0.00196	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCR1—multiple sclerosis	0.000233	0.00196	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CXCL13—multiple sclerosis	0.000233	0.00196	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000232	0.00196	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000232	0.00196	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000229	0.00193	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—FAS—multiple sclerosis	0.000226	0.0019	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000211	0.00178	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000206	0.00174	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000205	0.00173	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000203	0.00171	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—BCHE—multiple sclerosis	0.000202	0.0017	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CCL5—multiple sclerosis	0.0002	0.00169	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CYP24A1—multiple sclerosis	0.0002	0.00169	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CYP27B1—multiple sclerosis	0.0002	0.00169	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CXCR3—multiple sclerosis	0.000196	0.00165	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—GPR65—multiple sclerosis	0.000196	0.00165	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CCR2—multiple sclerosis	0.000191	0.00161	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000188	0.00159	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GPC5—multiple sclerosis	0.000183	0.00154	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000182	0.00153	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CCL5—multiple sclerosis	0.000182	0.00153	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000181	0.00153	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CCR5—multiple sclerosis	0.00018	0.00152	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CXCL13—multiple sclerosis	0.000179	0.00151	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCR1—multiple sclerosis	0.000179	0.00151	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000178	0.0015	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000177	0.00149	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CNR1—multiple sclerosis	0.000176	0.00148	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CYP24A1—multiple sclerosis	0.000169	0.00143	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CYP27B1—multiple sclerosis	0.000169	0.00143	CbGpPWpGaD
Amphetamine—SLC18A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000169	0.00142	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000168	0.00141	CbGpPWpGaD
Amphetamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000167	0.00141	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCL3—multiple sclerosis	0.000166	0.0014	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CCR5—multiple sclerosis	0.000164	0.00138	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000163	0.00138	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000162	0.00136	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000161	0.00136	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000161	0.00136	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000161	0.00135	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.00016	0.00135	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PTGER4—multiple sclerosis	0.00016	0.00135	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.000158	0.00134	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PGR—multiple sclerosis	0.000157	0.00133	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000156	0.00131	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GPC5—multiple sclerosis	0.000155	0.00131	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CXCR3—multiple sclerosis	0.000154	0.0013	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CD28—multiple sclerosis	0.000153	0.00129	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—RRM1—multiple sclerosis	0.000152	0.00128	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000152	0.00128	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCR2—multiple sclerosis	0.00015	0.00127	CbGpPWpGaD
Amphetamine—SLC22A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000146	0.00123	CbGpPWpGaD
Amphetamine—SLC22A5—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000145	0.00123	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000142	0.0012	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—POMC—multiple sclerosis	0.000141	0.00119	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00014	0.00118	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CNR1—multiple sclerosis	0.000138	0.00117	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SRM—multiple sclerosis	0.000138	0.00117	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—FAS—multiple sclerosis	0.000138	0.00116	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000137	0.00116	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CCL5—multiple sclerosis	0.000136	0.00115	CbGpPWpGaD
Amphetamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000135	0.00114	CbGpPWpGaD
Amphetamine—SLC6A4—NRF2 pathway—TGFB1—multiple sclerosis	0.000132	0.00112	CbGpPWpGaD
Amphetamine—SLC18A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000129	0.00109	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—RRM1—multiple sclerosis	0.000128	0.00108	CbGpPWpGaD
Amphetamine—CYP2A6—Biological oxidations—POMC—multiple sclerosis	0.000128	0.00108	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—POMC—multiple sclerosis	0.000128	0.00108	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCL3—multiple sclerosis	0.000128	0.00108	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000126	0.00106	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CCL2—multiple sclerosis	0.000125	0.00106	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—S1PR1—multiple sclerosis	0.000125	0.00105	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CXCL10—multiple sclerosis	0.000125	0.00105	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—PTGER4—multiple sclerosis	0.000123	0.00104	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000123	0.00104	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CXCR3—multiple sclerosis	0.000119	0.001	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000117	0.00099	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—RGS1—multiple sclerosis	0.000117	0.000985	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCR2—multiple sclerosis	0.000115	0.000974	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000114	0.000962	CbGpPWpGaD
Amphetamine—SLC6A2—NRF2 pathway—TGFB1—multiple sclerosis	0.000114	0.000961	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—TYK2—multiple sclerosis	0.000114	0.000959	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000113	0.000957	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—GPR65—multiple sclerosis	0.000111	0.000934	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CD86—multiple sclerosis	0.000109	0.00092	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000108	0.000915	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCL5—multiple sclerosis	0.000107	0.000905	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CNR1—multiple sclerosis	0.000107	0.000899	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—RGS1—multiple sclerosis	0.000106	0.000894	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—IL2—multiple sclerosis	0.000104	0.000879	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCR1—multiple sclerosis	0.000101	0.000854	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000101	0.000854	CbGpPWpGaD
Amphetamine—SLC6A3—NRF2 pathway—TGFB1—multiple sclerosis	0.000101	0.000851	CbGpPWpGaD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000101	0.000848	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—GPR65—multiple sclerosis	0.000101	0.000848	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—SPP1—multiple sclerosis	9.94e-05	0.000839	CbGpPWpGaD
Amphetamine—SLC18A2—Neuronal System—MAPK1—multiple sclerosis	9.89e-05	0.000834	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	9.77e-05	0.000824	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	9.75e-05	0.000822	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	9.75e-05	0.000822	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LINGO1—multiple sclerosis	9.72e-05	0.00082	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCR5—multiple sclerosis	9.67e-05	0.000816	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—POMC—multiple sclerosis	9.6e-05	0.00081	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CXCL10—multiple sclerosis	9.59e-05	0.000809	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL2RA—multiple sclerosis	9.53e-05	0.000804	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—IL6—multiple sclerosis	9.47e-05	0.000799	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—IL2—multiple sclerosis	9.46e-05	0.000798	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCR1—multiple sclerosis	9.19e-05	0.000776	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCL13—multiple sclerosis	9.19e-05	0.000776	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GPC5—multiple sclerosis	8.91e-05	0.000752	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—APOE—multiple sclerosis	8.8e-05	0.000742	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—BCHE—multiple sclerosis	8.71e-05	0.000735	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.57e-05	0.000723	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	8.43e-05	0.000711	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TAGAP—multiple sclerosis	8.43e-05	0.000711	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCL5—multiple sclerosis	8.26e-05	0.000697	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CD80—multiple sclerosis	7.95e-05	0.000671	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SRM—multiple sclerosis	7.76e-05	0.000654	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—IL6—multiple sclerosis	7.73e-05	0.000652	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.69e-05	0.000649	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	7.63e-05	0.000644	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—POMC—multiple sclerosis	7.56e-05	0.000638	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	7.47e-05	0.00063	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCR5—multiple sclerosis	7.44e-05	0.000628	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.41e-05	0.000625	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCL2—multiple sclerosis	7.39e-05	0.000624	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.39e-05	0.000623	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—RRM1—multiple sclerosis	7.39e-05	0.000623	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—BCHE—multiple sclerosis	7.37e-05	0.000622	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—S1PR1—multiple sclerosis	7.37e-05	0.000621	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—MAPK1—multiple sclerosis	7.23e-05	0.00061	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	7.19e-05	0.000607	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GPC5—multiple sclerosis	7.17e-05	0.000605	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PTGER4—multiple sclerosis	6.94e-05	0.000586	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TYK2—multiple sclerosis	6.71e-05	0.000566	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCR3—multiple sclerosis	6.71e-05	0.000566	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL3—multiple sclerosis	6.55e-05	0.000553	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCR2—multiple sclerosis	6.52e-05	0.00055	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PTGER4—multiple sclerosis	6.3e-05	0.000532	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RGS1—multiple sclerosis	6.26e-05	0.000528	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCR3—multiple sclerosis	6.09e-05	0.000514	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CNR1—multiple sclerosis	6.02e-05	0.000508	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GPR65—multiple sclerosis	5.94e-05	0.000501	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCR2—multiple sclerosis	5.92e-05	0.0005	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—MAPK1—multiple sclerosis	5.89e-05	0.000497	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—POMC—multiple sclerosis	5.81e-05	0.00049	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.77e-05	0.000487	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCL2—multiple sclerosis	5.69e-05	0.00048	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL2—multiple sclerosis	5.59e-05	0.000471	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—IL6—multiple sclerosis	5.56e-05	0.000469	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CNR1—multiple sclerosis	5.47e-05	0.000461	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	5.47e-05	0.000461	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	5.47e-05	0.000461	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL13—multiple sclerosis	5.43e-05	0.000458	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCR1—multiple sclerosis	5.43e-05	0.000458	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCL10—multiple sclerosis	5.42e-05	0.000457	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MMP9—multiple sclerosis	5.29e-05	0.000446	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—APOE—multiple sclerosis	5.24e-05	0.000442	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.11e-05	0.000431	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GPC5—multiple sclerosis	5e-05	0.000422	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCL10—multiple sclerosis	4.92e-05	0.000415	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—IL6—multiple sclerosis	4.73e-05	0.000399	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—STAT3—multiple sclerosis	4.7e-05	0.000397	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCL5—multiple sclerosis	4.67e-05	0.000394	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—POMC—multiple sclerosis	4.5e-05	0.00038	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—APOE—multiple sclerosis	4.43e-05	0.000374	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MYC—multiple sclerosis	4.37e-05	0.000369	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TGFB1—multiple sclerosis	4.36e-05	0.000368	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MAPK1—multiple sclerosis	4.27e-05	0.000361	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—BCHE—multiple sclerosis	4.24e-05	0.000358	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL5—multiple sclerosis	4.24e-05	0.000357	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCR5—multiple sclerosis	4.2e-05	0.000355	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—IL2RA—multiple sclerosis	4.14e-05	0.00035	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—RRM1—multiple sclerosis	4.14e-05	0.000349	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ALB—multiple sclerosis	4.1e-05	0.000346	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL3—multiple sclerosis	3.87e-05	0.000326	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCR5—multiple sclerosis	3.82e-05	0.000322	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—POMC—multiple sclerosis	3.81e-05	0.000321	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL2RA—multiple sclerosis	3.76e-05	0.000317	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTGER4—multiple sclerosis	3.72e-05	0.000314	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PGR—multiple sclerosis	3.67e-05	0.000309	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCR3—multiple sclerosis	3.6e-05	0.000303	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CD28—multiple sclerosis	3.56e-05	0.000301	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCR2—multiple sclerosis	3.5e-05	0.000295	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ALB—multiple sclerosis	3.47e-05	0.000293	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—POMC—multiple sclerosis	3.29e-05	0.000277	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL6—multiple sclerosis	3.28e-05	0.000277	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CNR1—multiple sclerosis	3.23e-05	0.000272	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—POMC—multiple sclerosis	2.98e-05	0.000252	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	2.92e-05	0.000246	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	2.91e-05	0.000245	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	2.65e-05	0.000224	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOE—multiple sclerosis	2.55e-05	0.000215	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CD86—multiple sclerosis	2.54e-05	0.000215	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL5—multiple sclerosis	2.5e-05	0.000211	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	2.43e-05	0.000205	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—BCHE—multiple sclerosis	2.38e-05	0.000201	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SPP1—multiple sclerosis	2.32e-05	0.000196	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCR5—multiple sclerosis	2.25e-05	0.00019	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	2.22e-05	0.000187	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL2—multiple sclerosis	2.21e-05	0.000186	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—POMC—multiple sclerosis	2.19e-05	0.000185	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOE—multiple sclerosis	2.05e-05	0.000173	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALB—multiple sclerosis	2e-05	0.000169	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CD80—multiple sclerosis	1.85e-05	0.000156	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—POMC—multiple sclerosis	1.76e-05	0.000149	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	1.72e-05	0.000145	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.69e-05	0.000142	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	1.57e-05	0.000132	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOE—multiple sclerosis	1.43e-05	0.000121	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL2—multiple sclerosis	1.3e-05	0.00011	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	1.3e-05	0.000109	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	1.23e-05	0.000104	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—POMC—multiple sclerosis	1.23e-05	0.000104	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALB—multiple sclerosis	1.12e-05	9.46e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	1.1e-05	9.25e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MYC—multiple sclerosis	1.02e-05	8.59e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	1.02e-05	8.57e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	9.97e-06	8.41e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6—multiple sclerosis	7.66e-06	6.46e-05	CbGpPWpGaD
